IntroductionThe global mesenchymal stem cells market is witnessing a significant transformation as advancements in ...

In today’s fast-paced biotechnology landscape, AMSA Biotech emerges as a trailblazer in the field of regenerative medicine. Driven by a vision of science-led healing and personalized care, the company ...

Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies into the clinic.

Funding will enable company to expand research capacity and scale up unique genome editing technology designed to treat ...

A novel study has unveiled a technique that enhances stem cell therapy for neurodegenerative diseases by combining magnetic ...

Presented positive 4- and 12-week clinical results of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplan ...

plush-carpeted hospital is getting ready to welcome its first patients. Building on the Nobel-prizewinning work of stem-cell scientist Shinya Yamanaka, researchers across the country are crafting ...

Bolstered management team with hires of Chief Executive Officer and Chief Medical Officer with deep biopharmaceutical experienceAnnounced selection of IL15-superagonist as first payload to be ...

"We're proud to be a Semifinalist team of XPRIZE Healthspan, a 7-year, $101 million global competition that aims to ...